RimonabantRimonabant (also known as SR141716; trade names Acomplia, Zimulti) is an anorectic antiobesity drug approved in Europe in 2006 but was withdrawn worldwide in 2008 due to serious neurological and psychiatric side effects; it was never approved in the United States. Read from the Drugbox of the Wikipedia article Rimonabant, revision 1370371728.

Property

Value

Formula

C22H21Cl3N4O, 463.79 g/mol

Protein binding

100 %

Elimination half-life

180 h

The compounds of every Wikipedia article carrying a Chembox or a Drugbox, refreshed daily, with the values their infoboxes give. The pages need JavaScript; the API does not.